Outcomes Similar After TAVR in Bicuspid, Tricuspid Anatomy
All-cause mortality and stroke are comparable at 30 days and one year after transcatheter aortic valve replacement (TAVR) among patients with bicuspid and tricuspid valve stenosis, according to a study published online May 27 in JACC: Cardiovascular Interventions.Source: HealthDay
Opinion: Hydroxychloroquine And Azithromycin For COVID-19: Benefits TBD, Risks Clear
In the midst of a pandemic, lots of people have ideas for cures. We are desperate for therapies and the virus can be deadly. The problem is that the presumptive cure can add danger to the disease, rather than mitigate it.Source: Forbes
Coronavirus infection may cause lasting damage throughout the body, doctors fear
For a world grappling with the new coronavirus, it’s becoming increasingly clear that even when the pandemic is over, it won’t really be over. Now doctors are beginning to worry that for patients who have survived COVID-19, the same may be true.Source: Los Angeles Times
Long Term Results Favor CABG—Is This Surprising?
Ever since the first interventional cardiologist threaded a catheter into an occluded artery in the heart and inflated a balloon to widen the narrowed artery, a turf war has ebbed and flowed between interventionalists and surgeons over the best way to treat CAD.Source: Physicians Weekly
ERs are seeing up to 60% fewer heart attack patients as those infected with coronavirus fill hospital beds but cardiac emergencies mysteriously 'disappear'
Emergency rooms across the U.S. are seeing less than half of usual number of heart attack patients as beds are filled by those infected with coronavirus.Source: Mary Kekatos
Registry data show lower event rates vs. trial data for LAA closure device
Patients with atrial fibrillation who underwent left atrial appendage occlusion with an FDA-approved device had lower rates of major in-hospital adverse events compared with previous trials assessing the device.Source: Healio
Hospitals seeing ‘a previously unimaginable shift’ due to COVID-19—are patients afraid to seek medical attention?
As COVID-19 continues to keep healthcare providers busy, fewer patients appear to be seeking care for other serious issues, including cardiovascular complications such as heart attack and stroke.Source: Cardiovascular Business
LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout
In the first 3 years of the LAAO Registry, the Watchman left atrial appendage closure device was implanted with rates of in-hospital safety outcomes that were comparable to those seen in the pivotal trials, despite being used in higher-risk patients, new data show.Source: TCTMD
WATCHMAN atrial occlusion device shows favorable safety record in U.S. clinical practice
Procedures to implant the WATCHMAN left atrial occlusion device had a high implant success rate and a low rate of in-hospital complications in an analysis of more than 38,000 procedures presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).Source: Medical Xpress
LAAO Registry Shows Higher Success Rates, Lower Adverse Outcomes Than Clinical Trials
Patients undergoing left atrial appendage occlusion (LAAO) experienced higher success rates and lower rates of in-hospital major adverse events, compared with those reported in randomized clinical trials.Source: American College of Cardiology